NY governor authorizes medical marijuana (Update)

New York Governor Andrew Cuomo announced Wednesday he will authorize the medical use of marijuana, making his the 21st US state to do so and one of the biggest.

Cuomo, a Democrat who has in the past opposed such a measure, announced a limited pilot program to serve the state of 19.5 million people.

"We will establish a program allowing up to 20 hospitals to prescribe medical marijuana," he said during his annual state of the state speech in Albany.

Cuomo argued that research has suggested marijuana, which is widely but illegally used for recreational purposes, can help patients "manage the pain and treatment of cancer and other serious illnesses."

"We will monitor the program to evaluate effectiveness in the feasibility of (a) medical marijuana system," he added.

Cuomo, 56, who last year described his support for decriminalizing the possession of up to 15 grams of the drug, is likely to proceed by decree, after four previous attempts to legalize medical marijuana failed to get traction among the state's lawmakers.

The announcement comes as part of a growing movement to relax US laws on marijuana.

According to an October 2013 Gallup poll, 58 percent of Americans favor legalizing marijuana.

Including New York, the drug will soon be allowed for medical reasons to various degrees in 21 of 50 states and in the capital Washington.

The first state to legalize medical marijuana was California, in 1996. A prescription can be obtained there for conditions as minor as a bad back.

In Massachusetts, where the drug was legalized by referendum in November 2013, patients can possess "no more marijuana than is necessary for the patient's personal, medical use" for up to a 60-day supply, to ease suffering from cancer, glaucoma, HIV or AIDS, Hepatitis C, Parkinson's disease and other serious conditions.

Vermont authorizes registered patients to possess "no more than two mature marijuana plants, seven immature plants and two ounces of usable marijuana."

Oregon authorizes 680 grams, including for people who suffer from post-traumatic stress disorder.

Colorado has gone even further. Since January 1, recreational users older than 21 can legally buy up to 28 grams of cannabis for their own enjoyment regardless of their medical status.

The state of Washington took a similar measure, set to take effect in the coming months.

Authorities in both states oversee the production, distribution and marketing of cannabis there.

At the federal level, the sale and possession of marijuana remains illegal. But in October 2009, the White House sent a memo urging federal prosecutors not to pursue cases against people distributing the drug for therapeutic purposes.

Cuomo's announcement comes just days after Bill de Blasio—further to the left than the governor—became New York City mayor.

Cuomo, who's up for re-election at the end of the year, highlighted the economic success of his state, the necessity to lower business taxes there and to modernize the school system.

He has been tapped as a possible presidential candidate in 2016, along with his moderate Republican counterpart in neighboring New Jersey, Chris Christie.

New Jersey already authorizes marijuana for medical use within a strict framework. That state's law has recently been expanded to include certain childhood maladies.

add to favorites email to friend print save as pdf

Related Stories

New York may allow medical marijuana use: report

Jan 05, 2014

New York is planning to loosen its marijuana laws to allow limited use of the drug by people suffering serious illness, the New York Times reported Saturday, citing state officials.

US to tolerate recreational marijuana in two states

Aug 29, 2013

President Barack Obama's administration ceded ground Thursday in the US war on drugs, saying it will not dispute the legalization of recreational marijuana in Colorado and Washington state.

Recommended for you

Boxed warnings are common in novel therapeutics

Aug 19, 2014

(HealthDay)—Boxed warnings are common on recent drug approvals, and many occur years after approval, according to a research letter published online Aug. 15 in JAMA Internal Medicine.

AstraZeneca says DOJ closes probe into drug trial

Aug 19, 2014

British drugmaker AstraZeneca says the U.S. Department of Justice has closed its investigation into a clinical trial of the company's blood thinner Brilinta, and plans no further action.

Perampanel for epilepsy: Still no proof of added benefit

Aug 19, 2014

The drug perampanel (trade name Fycompa) has been approved since July 2012 as adjunctive ("add-on") therapy for adults and children aged 12 years and older with epileptic fits (seizures). In a new early benefit assessment ...

User comments